Supplemental Table 5. Modified Poisson regression analysis of APOA-I and HDL-C/P ratio in 5-year risk of plaque progression and plaque incidence in participants without lipid-lowering medications, respectively.

	Plaque Progression		Plaque Incidence
	RR (95% CI)	P value	RR (95% CI)	P value
APOA-I (mg/dL)
＜134.7	Ref		Ref
134.7 - 150.4	1.09 (0.87 - 1.38)	0.452	1.20 (0.90 - 1.62)	0.216
≥ 150.5	0.99 (0.68 - 1.45)	0.957	1.10 (0.69 - 1.77)	0.686
HDL-C/P ratio
＜44.8	Ref		Ref
44.8 - 52.2	1.28 (1.03 - 1.58)	0.024	1.24 (0.97 - 1.59)	0.081
≥ 52.3	1.52 (1.09 - 2.12)	0.013	1.51 (1.05 - 2.17)	0.024

RRs (95% CI) were calculated by modified Poisson regression analysis, and all substantial models were adjusted for age (per 5 years), sex, BMI, diabetes, smoking, systolic blood pressure (per 10mmHg), anti-hypertensive medications, lipid-lowering medications, log-transformed high-sensitivity C-reactive protein levels, log-transformed triglyceride, low-density lipoprotein cholesterol (per 20mg/dL), and HDL particle size (per 0.4 nm).